The effect of modified donanemab titration on amyloid-related imaging abnormalities with edema/effusions and amyloid reduction: 18-month results from TRAILBLAZER-ALZ 6. - Wang H; Nery ESM; Ardayfio P; Khanna R; Svaldi DO; Shcherbinin S; Xu W; Andersen SW; Hauck PM; Brooks DA; Collins EC; Salloway S; et al. (The journal of prevention of Alzheimer's disease, 2025)